Kimberlee C. Drapkin

Chief Financial Officer, EPIX Pharmaceuticals, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 3, 2026Granted 35,500 shares of Acumen Pharmaceuticals, Inc.⁷
Jun 30, 2025Returned to company 13,794 shares of Proteostasis Therapeutics (United States)⁸
Jun 25, 2025Granted 6,000 shares of Proteostasis Therapeutics (United States)¹⁰
Jun 23, 2025Shares withheld for tax 4,706 shares at $0.26 of Proteostasis Therapeutics (United States)¹⁰
Jun 23, 2025Exercised options 12,500 shares at $0.61 of Proteostasis Therapeutics (United States)¹⁰
Jun 4, 2025Granted 12,800 shares of Acumen Pharmaceuticals, Inc.¹¹
May 3, 2023U 40,267 shares of Jounce Therapeutics⁹
May 3, 2023U 25,751 shares of Jounce Therapeutics⁹
Jan 10, 2023Sold 7,781 shares at $1.12 of Jounce Therapeutics¹²
Jan 9, 2023Sold 6,315 shares at $1.10 of Jounce Therapeutics¹²
Feb 1, 2022Granted 27,500 shares of Jounce Therapeutics¹³
Jan 10, 2022Sold 8,222 shares at $6.65 of Jounce Therapeutics¹⁴
Jan 7, 2022Sold 4,595 shares at $7.30 of Jounce Therapeutics¹⁴

The numbers on this page point here. Each one links to the record it came from.